Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation.

Gregory Y H Lip, Dong Cheng, Jenny Jiang, Chuan Gao, Rupesh Subash, Elisabeth Vodicka, Anandkumar Dubey, Puza P Sharma, Anakha Vettumthara Unnikrishnan, Kishorekumar Mathivanan, Steven Deitelzweig